挪威孕产妇流感与新冠疫苗接种覆盖率及错过机会:基于人群登记研究
该研究纳入2023年10月1日至2024年9月30日在挪威分娩的女性,通过国家免疫登记与出生登记链接分析孕期流感与新冠疫苗接种率。结果显示流感疫苗总体覆盖率为29.9%,新冠疫苗为12.1%,仅11.4%同时接种两种疫苗;25岁及以下女性接种率最低(<19%),2023年11月后存在明显错过接种机会。
要点
- 挪威2023/24年度孕产妇流感疫苗覆盖率为29.9%,新冠疫苗仅12.1%。
- 仅11.4%孕妇同时接种流感与新冠疫苗,25岁及以下女性接种率最低(<19%)。
- 2023年11月后接种率趋于平台,2月分娩者流感疫苗覆盖率最高(50.8%)。
核心结论
- 2023/24年度挪威孕产妇流感与新冠疫苗接种覆盖率仍较低,2023年11月后存在错过接种机会。
- 25岁及以下孕妇接种率最低,需加强努力以提高接种覆盖率并减少保护缺口。
研究设计与样本
- 基于人群的登记研究,纳入2023年10月1日至2024年9月30日在挪威分娩的女性。
- 流感与新冠疫苗接种数据来自国家免疫登记(2023年10月1日至2024年5月10日),并与挪威医学出生登记链接。
主要发现
- 流感疫苗总体覆盖率为29.9%(15,915/53,161),其中22.3%(11,856/53,161)在孕中晚期接种。
- 流感疫苗覆盖率从10月的16.4%(7,287/44,454)升至11月的26.4%(12,982/49,170),此后趋于平台。
- 2月分娩的女性流感疫苗覆盖率最高(50.8%;2,159/4,248),之后下降。
- 新冠疫苗覆盖率为12.1%(6,423/53,161),其中10.1%(5,349/53,161)在孕中晚期接种,趋势与流感类似。
- 11.4%的孕妇同时接种了两种疫苗;25岁及以下女性接种率最低(<19%)。
临床怎么用
- 应关注孕产妇流感与新冠疫苗接种的低覆盖率,尤其针对25岁及以下孕妇加强接种推荐。
- 2023年11月后接种率平台提示需在孕期持续提供接种机会,避免错过窗口期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDPregnant women and their newborns are at increased risk of severe outcomes from influenza and COVID-19 infections; maternal vaccination is recommended. However, no routine surveillance of maternal vaccine coverage exists in Norway.AIMTo provide insights into vaccination coverage and timing during pregnancy.METHODSThis population-based registry study included women who gave birth in Norway during 1 October 2023-30 September 2024. Data on influenza and COVID-19 vaccinations administered during 1 October 2023-10 May 2024 were obtained from the national immunisation registry and linked to birth data from the Medical Birth Registry Norway. Cumulative coverage included vaccines administered during pregnancy, with sub-analyses focusing on second and third trimester vaccinations, month of delivery and maternal age.RESULTSOverall influenza vaccination coverage was 29.9% (15,915/53,161), with 22.3% (11,856/53,161) vaccinated in the second or third trimester. Coverage increased from 16.4% (7,287/44,454) in October to 26.4% (12,982/49,170) in November and plateaued thereafter. Coverage peaked among women delivering in February (50.8%; 2,159/4,248) and declined afterwards. COVID-19 vaccination coverage was 12.1% (6,423/53,161) with 10.1% (5,349/53,161) in the second or third trimester, following a similar pattern to influenza. Overall, 11.4% received both vaccines. The lowest uptake (< 19%) was among women aged 25 years or younger.CONCLUSIONCoverage of maternal influenza and COVID-19 vaccinations for 2023/24 remained low, with missed opportunities to reach pregnant women beyond November 2023. Overall, the coverage was lowest among women aged 25 years or younger. Strengthened efforts are needed to increase vaccination coverage among pregnant women and reduce gaps in protection.
引用
- Stecher M, Greve-Isdahl M, Dahl J, et al. Missed opportunities for maternal immunisation against influenza and COVID-19, Norway, October 2023 to May 2024: a population-based registry study. Euro Surveill. 2026. PMID: 41716084. doi:10.2807/1560-7917.ES.2026.31.7.2500504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。